Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on May 9, 2025
Essential Thrombocythemia (ET) Market Key Trend: Advancement in Personalized Medicine
EIN Presswire
·
May 9, 2025
The Business Research Company's Essential Thrombocythemia (ET) Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /EINPresswire.com/ -- The Business Research Company’s …
Cryptococcosis Market Forecast 2025–2034: Emerging Treatments & Market Expansion
EIN Presswire
·
May 9, 2025
The Business Research Company’s Cryptococcosis Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /EINPresswire.com/ -- How Big Is the Cryptococcosis Market and How Fast Is It …
Activists Mark Luigi Mangione’s Birthday With Aerial Protest as Times Square Billboard on Jury Rights Explodes Online
GlobeNewswire
·
May 9, 2025
Image by POPNYC NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Two major public actions are unfolding in New York City this week to highlight systemic injustice in both the healthcare and criminal legal systems. Though independently organized, both coincide …
U.S. 503B Compounding Pharmacies Market Projected To Witness Massive Growth, 2025-2032 | Athenex, Inc., Avella Specialty
EIN Presswire
·
May 9, 2025
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- The latest report (2025-2032) on the U.S. 503B Compounding Pharmacies Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the …
U.S. Corporate Wellness Market Set to Witness Significant Growth by 2025-2032|Ayco, Aquila, BSDI, Aduro, Active Wellness
EIN Presswire
·
May 9, 2025
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- U.S. Corporate Wellness Market is estimated to be valued at USD 16.07 Bn in 2025 and is expected to reach USD 30.14 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.4% from …
GLP-1 Receptor Agonist Market Projected To Witness Substantial Growth, 2025-2032: Sanofi, Novo Nordisk A/S, AstraZeneca
EIN Presswire
·
May 9, 2025
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- The GLP-1 receptor agonist market would be worth USD 28.19 billion in 2025 and grow at a compound annual growth rate (CAGR) of 12.3% to reach USD 63.54 billion by 2032. The latest …
U.S. Home Healthcare Market Set to Witness Significant Growth by 2025-2032 | Medline Industries Inc., Medtronic Plc, 3M
EIN Presswire
·
May 9, 2025
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- U.S. Home Healthcare Market is estimated to be valued at USD 26.59 Bn in 2025 and is expected to reach USD 40.78 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.3% from …
Rfid In Healthcare Market Projected To Witness Massive Growth, 2025-2032 | Microchip Technology, Accenture, Hitachi, 3M
EIN Presswire
·
May 9, 2025
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- Rfid In Healthcare Market is estimated to be valued at USD 11.9 Bn in 2025 and is expected to reach USD 43.39 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 20.3% from …
Type 1 Diabetes Market Set to Witness Significant Growth by 2025-2032: Biocon, Novo Nordisk, Gan & Lee Pharmaceuticals
EIN Presswire
·
May 9, 2025
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- Global type 1 diabetes market is estimated to be valued at USD 16.97 Bn in 2025 and is expected to reach USD 26.22 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.4% …
Europe Iv Hydration Therapy Market Projected To Witness Substantial Growth, 2025-2032 | REVITA, IV Boost UK, ELIXIR
EIN Presswire
·
May 9, 2025
BURLINGAME, CA, UNITED STATES, May 9, 2025 /EINPresswire.com/ -- The Global Europe Iv Hydration Therapy Market is expected to grow at CAGR 7.2% from 2025 to 2032. The latest report (2025-2032) on the Europe Iv Hydration Therapy Market by Coherent …
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
GlobeNewswire
·
May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that it will present full 12 …
Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting
GlobeNewswire
·
May 9, 2025
First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) Compared to Current Standards of Care in Matched Patient …
HealthEquity Announces First Quarter Earnings Release Date Presentations at Investor Conferences
GlobeNewswire
·
May 9, 2025
DRAPER, Utah, May 09, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced plans to release its first quarter of fiscal 2026 financial …
Theriva Biologics anuncia el cierre de una oferta pública de 7,5 millones de dólares
GlobeNewswire
·
May 9, 2025
ROCKVILLE, Maryland, May 09, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), («Theriva» o la «empresa»), una empresa diversificada en fase clínica que desarrolla terapias diseñadas para tratar el cáncer y enfermedades relacionadas en …
Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases
GlobeNewswire
·
May 9, 2025
New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following intra-cerebrospinal fluid administration in non-human primates Data …
Publication relative à des notifications de transparence
GlobeNewswire
·
May 9, 2025
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 9 mai 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations …
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …
Publication relating to transparency notifications
GlobeNewswire
·
May 9, 2025
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), May 9, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings …
Olema Oncology to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 9, 2025
SAN FRANCISCO, May 09, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA) a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast …
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025
GlobeNewswire
·
May 9, 2025
SUNNYVALE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and …